TGF-β1 and IGF-1 and Anastomotic Recurrence of Crohn’s Disease After Ileo-Colonic Resection-Reference-Cited by-同舟云学术

TGF-β1 and IGF-1 and Anastomotic Recurrence of Crohn’s Disease After Ileo-Colonic Resection

Published:2008-08-13 Issue:11 Volume:12 Page:1981-1990
ISSN:1091-255X
Container-title:Journal of Gastrointestinal Surgery
language:en
Short-container-title:J Gastrointest Surg

Author:

Scarpa Marco,Bortolami Marina,Morgan Susan L.,Kotsafti Andromachi,Ruffolo Cesare,D’Incà Renata,Bertin Eugenia,Polese Lino,D’Amico Davide F.,Sturniolo Giacomo C.,Angriman Imerio

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s11605-008-0641-5.pdf

Reference37 articles.

1. Williams JG, Wong WD, Rothenberger DA, Goldberg SM. Recurrence of Crohn’s disease after resection. Br J Surg 1991;78:10–19. doi: 10.1002/bjs.1800780106 .

2. Tytgat GNJ, Mulder GJI, Brummerlkamp WH. Endoscopic lesion in Crohn’s disease early after ileocecal resection. Endoscopy 1988;20:260–262.

3. Wolff BG. Factors determining recurrence following surgery for Crohn’s disease. World J Surg 1998;22:364–369. doi: 10.1007/s002689900398 .

4. Boreley NR, Mortensen NJ, Jewell DP. Preventing postoperative recurrence of Crohn’s disease. Br J Surg 1997;84(11):1493–1502. doi: 10.1002/bjs.1800841104 .

5. Moskovitz D, McLeod RS, Greenberg GR, Cohen Z. Operative and environmental risk factors for recurrence of Crohn’s disease. Int J Colorectal Dis 1999;14(4–5):224–226. doi: 10.1007/s003840050215 .

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TGF-β signaling in health, disease and therapeutics;Signal Transduction and Targeted Therapy;2024-03-22

2. Anastomotic Techniques for Abdominal Crohn's Disease: Tricks and Tips;Journal of Laparoendoscopic & Advanced Surgical Techniques;2021-08-01

3. Intestinal Activation of pH-Sensing Receptor OGR1 [GPR68] Contributes to Fibrogenesis;Journal of Crohn's and Colitis;2018-08-25

4. Factors Promoting Development of Fibrosis in Crohn’s Disease;Frontiers in Medicine;2017-07-07

5. TAK1 is a key modulator of the profibrogenic phenotype of human ileal myofibroblasts in Crohn's disease;American Journal of Physiology-Gastrointestinal and Liver Physiology;2015-09-15